Link Pharma Chem Ltd.
Snapshot View

View in App

Prices View details >>

55.90 +0.40 ▲0.7%

09 February 2023, 02:16:00 PM
Volume: 2,477

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.linkpharmachem.co.in
Market Cap 24.02 Cr.
Enterprise Value(EV) 30.98 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 3.71 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 14.58 Trailing Twelve Months Ending 2022-09
Industry PE 30.86 Trailing Twelve Months Ending 2022-09
Book Value / Share 34.14 Trailing Twelve Months Ending 2022-09
Price to Book Value 1.58 Calculated using Price: 54.10
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.44 Cr. 4,440,568 Shares
FaceValue 10
Company Profile
Link Pharma Chem, incorporated on December 28, 1984 is a manufacturer of thionyl chloride.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.72%
1 Week
+3.14%
1 Month
-0.18%
3 Month
+33.10%
6 Month
+22.45%
1 Year
+12.59%
2 Year
+95.80%
5 Year
+34.38%
10 Year
+712.50%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 4.97 -23.07 6.83 2.58 12.34 6.53 8.71 9.04 13.92
Return on Capital Employed (%) 9.32 -8.74 9.83 9.26 15.38 10.31 12.87 13.58 16.57
Return on Assets (%) 2.01 -8.35 2.70 1.31 6.61 3.74 5.14 4.82 6.84

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 11 8 9 9 10 10 11 13 14 15
Non Curr. Liab. 6 8 1 2 3 3 4 4 4 3
Curr. Liab. 10 9 7 7 4 5 3 9 11 12
Minority Int.
Equity & Liab. 26 26 18 17 17 18 19 26 29 31
Non Curr. Assets 17 18 10 10 11 11 10 11 15 15
Curr. Assets 10 8 7 7 7 7 9 15 14 15
Misc. Exp. not W/O
Total Assets 26 26 18 17 17 18 19 26 29 31

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 24 18 12 16 24 25 25 35 54 45
Other Income 0 0 3 0 0 0 0 0 1 0
Total Income 24 18 15 16 24 25 26 35 54 46
Total Expenditure -21 -18 -13 -14 -21 -22 -23 -32 -50 -42
PBIDT 3 -1 3 2 3 2 3 3 4 4
Interest -1 -1 -1 -1 -1 0 0 0 0 -1
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
Taxation 0 1 0 0 0 0 0 -1 -1 0
Exceptional Items
PAT 1 -2 1 0 1 1 1 1 2 2
Adjusted EPS 1 -5 1 1 3 1 2 2 4 4

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -1 1 5 -4 2 4 1 3 5 -1
Cash Fr. Inv. -1 -1 -3 9 -1 -1 -1 -2 -2 -5
Cash Fr. Finan. 2 0 -1 -6 -1 -3 0 1 0 2
Net Change 0 0 1 -1 0 0 2 2 -4
Cash & Cash Eqvt 0 0 1 0 0 0 0 2 4 0

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 51.49 51.49 51.49 51.49 51.49 51.49 51.49 51.49 51.49
Public 48.51 48.51 48.51 48.51 48.51 48.51 48.51 48.51 48.51
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 02 Feb 2023
Board Meeting Intimation for Intimation Of Board Meeting For Approval Of Unaudited Financial Results For The Quarter Ended December 31 2022.
LINK PHARMA CHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2023 inter alia to consider and approve Unaudited Financial Results for the quarter ended December 31 2022.
Wed, 01 Feb 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
Mon, 16 Jan 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.

Technical Scans View Details >>

Wed, 08 Feb 2023
High Delivery Percentage High Delivery Percentage
Closing Below Previous Low Closing Below Previous Low
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months
High Increase in 2 Years High Increase in 2 Years

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 243,148.61 1,006.40 -0.6%
Cipla Ltd. 83,886.47 1,022.50 -1.6%
Dr. Reddy's Laboratories Ltd. 74,707.50 4,493.95 +0.1%
Divi's Laboratories Ltd. 74,340.49 2,816.00 +0.6%
Apollo Hospitals Enterprise Ltd. 63,077.61 4,392.25 +0.0%
Torrent Pharmaceuticals Ltd. 52,675.65 1,541.95 -0.9%
Zydus Lifesciences Ltd. 47,993.66 474.05 +0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.66 1,006.40 -0.6%
Cipla Ltd. Consolidated 2022-12 31.80 1,022.50 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.50 4,493.95 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-12 31.01 2,816.00 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 75.13 4,392.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 63.19 1,541.95 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.29 474.05 +0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.39 1,006.40 -0.6%
Cipla Ltd. Consolidated 2022-12 3.70 1,022.50 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.39 4,493.95 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-12 5.98 2,816.00 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.54 4,392.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.24 1,541.95 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.78 474.05 +0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,006.40 -0.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,022.50 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,493.95 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,816.00 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,392.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,541.95 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 474.05 +0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,006.40 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,022.50 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,493.95 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,816.00 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,392.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,541.95 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 474.05 +0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,006.40 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,022.50 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,493.95 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,816.00 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,392.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,541.95 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 474.05 +0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,006.40 -0.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,022.50 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,493.95 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,816.00 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,392.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,541.95 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 474.05 +0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,006.40 -0.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,022.50 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,493.95 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,816.00 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,392.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,541.95 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 474.05 +0.0%

FAQ's On Link Pharma Chem Ltd.

What is Link Pharma Chem share price?
Can I buy Link Pharma Chem shares now?
What is the Market Cap of Link Pharma Chem?
What are the key metrics to analyse Link Pharma Chem?
What is the 52 Week High and Low of Link Pharma Chem?
What is the trend of Link Pharma Chem share price?